On some statistical methods for analysis of combination drug studies

To be discussed are the practical considerations in the use of some statistical methods to evaluate clinical data for combination antihypertensive agents. The issues of interest concern efficacy and dose-response in a factorial clinical trial for multiple dose combinations. Discussions cover fixed-dose combination studies.

[1]  E. Laska,et al.  Testing whether an identified treatment is best. , 1989, Biometrics.

[2]  Wampler Gl,et al.  Review of the application of response surface methodology in the combination therapy of cancer , 1986 .

[3]  S. N. Roy.  On a Heuristic Method of Test Construction and its use in Multivariate Analysis , 1953 .

[4]  J. Overall,et al.  The superiority of a drug combination over each of its components. , 1989, Statistics in medicine.

[5]  George E. P. Box,et al.  Empirical Model‐Building and Response Surfaces , 1988 .

[6]  On identifying a positive dose-response surface for combination agents. , 1992, Statistics in medicine.

[7]  George Y. H. Chi,et al.  Response Surface and Factorial Designs for Combination Antihypertensive Drugs* , 1990 .

[8]  G Y Chi,et al.  Testing for the existence of a desirable dose combination. , 1993, Biometrics.

[9]  H. Akaike.  A new look at the statistical model identification , 1974 .

[10]  H M Hung.  Two-stage tests for studying monotherapy and combination therapy in two-by-two factorial trials. , 1993, Statistics in medicine.

[11]  H. I. Patel.  Comparison of treatments in a combination therapy trial. , 1991, Journal of biopharmaceutical statistics.

[12]  Y. Hochberg.  A sharper Bonferroni procedure for multiple tests of significance , 1988 .

[13]  S. Snapinn,et al.  Evaluating the efficacy of a combination therapy. , 1987, Statistics in medicine.

[14]  L. Sheiner,et al.  Study designs for dose‐ranging , 1989, Clinical pharmacology and therapeutics.